SourceOne Global Partners has announced the strategic launch of the VESIsorb® natural self-assembling association colloid delivery system for coenzyme Q10 (CoQ10) in the medical professional channel of distribution. Douglas Laboratories, Pittsburgh, PA, a member of the Atrium Innovations Group, a premier worldwide firm known for its leadership in innovating technology, has partnered with SourceOne and is first to market.
“The need for supplementation with CoQ10 is clear and has never been greater, especially with the dramatic increase in the number of people taking statin drugs for cholesterol reduction,” observed Dr. Andrew Halpner, Vice President of New Product Development and Technical Services for Douglas Laboratories. “Finding novel ways to significantly improve lipid absorption has always been a challenge. This technology addresses the low relative bioavailability of natural bio-actives like CoQ10 exhibiting poor water solubility but high membrane permeability,” added Halpner.
Douglas Laboratories has introduced the VESIsorb® delivery system in a CoQ10 formula, Citrus Solu-Q™. It is delivered in a novel, proprietary two-piece liquid-filled hard shell capsule, Caplique™, an exclusive from AquaCap, a member of Atrium Innovations’ family of companies.
Douglas Lioon, CEO of Douglas Laboratories, explained, “We only work with those technologies and ingredients that have outstanding scientific evidence. After all, a physician’s entire reputation is on the line when recommending professional dietary supplements for cardiovascular support like Citrus Solu-Q™. As more patients exhibit adverse cardiovascular factors and their physicians seek to integrate nutraceuticals for cardiovascular support, our Citrus Solu-Q™ is a verifiably effective tool in the patient-care matrix.”
Developed by Vesifact, Baar, Switzerland, VESIsorb® is protected worldwide by multiple U.S. and international granted and pending patents. The VESIsorb® delivery system is a natural self-assembling colloid delivery system that has been clinically proven to increase absorption of medical, nutraceutical, and cosmetic ingredients. In all the clinical studies reviewed, no other CoQ10 formulation has reached the peak absorption blood level demonstrated with the VESIsorb® delivery system, branded CoQsource® by SourceOne. In addition to offering a Caplique™, SourceOne also makes available CoQsource® in soft gels and as a powder for capsules, drink mixes, stick packs and more.
“With the VESIsorb® delivery system, SourceOne can now offer bio-enhanced ingredients and proprietary formulas containing CoQ10 in either the ubiquinone or ubiquinol (QH) forms,” said Jesse Lopez, founder and CEO of SourceOne. “Perhaps even more compelling is our ability to deliver proprietary Omega-3 and CoQ10 combinations as well as using VESIsorb® to significantly improve the absorption of other natural lipophilic bio-actives such as vitamin D, resveratrol, citrus flavonoids, tocotrienols, and gamma-tocopherols,” said Lopez.
He added, “This naturally self-assembling colloidal delivery system enables us to meet the growing demand for enhanced bioavailability of these unique science-based ingredients and proprietary formulas taking their absorption and efficacy to the next level, truly making SourceOne your first choice for heart healthy ingredient solutions.”
About SourceOne™ Global Partners
SourceOne™ Global Partners, headquartered in Chicago, IL, represents a new breed of ingredient supplier, partnering with manufacturing clients to introduce powerfully branded, science-driven products to market with unique product positioning and compelling consumer presence. SourceOne was conceived as a company whose core competency would be to integrate legitimate science with strong trade and consumer branding. It partners with leading suppliers worldwide to source and offer patented ingredients supported by proprietary science as part of turnkey marketing programs that dramatically increases the odds for market success.
About Douglas Laboratories
With worldwide headquarters located in Pittsburgh, Pennsylvania, Douglas Laboratories currently offers approximately 700 branded nutraceutical products along with new products introduced on a continuing basis. Working with an experienced research staff of PhDs and a world-renowned medical advisory board, Douglas Laboratories’ commitment to bring innovative, clinically supported products to the marketplace to support patient needs is unsurpassed.
About Vesifact AG
A vital link between current research and private industry, Vesifact is a spin-off from the Swiss Federal Institute of Technology, Zurich (ETH Zürich). Innovative technology and know-how are developed in Vesifact’s laboratories and upscaled at its production units. They are then applied to commercial products before being transferred to the marketplace. In this way, Vesifact brings the latest know-how to exactly where it is most needed.
Vesifact laboratories and R&D facilities meet the ever increasing requirements for top-level research, product development, and innovation. Vesifact produces carrier systems that take medical, nutraceuticals, and cosmetic ingredients to enhance performance. Vesifact thus fulfils ever-increasing requirements for innovative dosage forms and application technologies and offers cutting edge-solutions.